Stockreport

Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients

Harrow Health, Inc.  (HROW) 
Last harrow health, inc. earnings: 11/13 04:21 pm Check Earnings Report
PDF Existing Klarity-C Patients to Have Access to VEVYE for $59 Per Bottle NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare phar [Read more]